- We know that the FDC también es util para oncho, lf, scabies y demás pero tenemos que elegir una disease of particular interest to perform the particular studies. So far the achievements have been: submission to EMA through art 58. the main target is leading the way to prequalification to WHO. We did the pivotal trial that demonstrated safety efficacy against T. Trichiura.
- Our current main challenges are safety and acceptability. We've had conversations with the department in Geneva to align our strategies.
- Evaluation of implementation strategies, pathways to programs and an access plan.
- We look for your interes
- We look for your expertise in these 3 aspects. Our interest is go beyond the science limited to STH and a vision of global health and a program of implementation.
FMS
9 months ago